Pustules, Vesicles, Bullae, and Erosions

Obstetric and Gynecologic Dermatology

Volumn , Issue , 2008, Pages 217-239

  Edwards, Libby ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b CAROLINAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957300122     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7234-3445-0.10020-7     Document Type: Chapter

References (38)

1. J.E. Malkin (2004) Epidemiology of genital herpes simplex virus infection in developed countries. Herpes 11(Suppl 1), 2A-23A.
2. F. Xu, M.R. Sternbery, B.J. Kottiri, et al. (2006) Trends in herpes simplex virus type 2 and type 2 seroprevalence in the United States. J.A.M.A. 296 964-973.
3. 2006 STD Treatment Guidelines. From the website of the Centers for Disease Control and Prevention. Available online at: http://www.cdc.gov/std/stats/syphilis.htm.
4. S.L. Sacks (2004) Famciclovir suppression of asymptomatic and symptomatic recurrent anogenital herpes simplex virus shedding in women: a randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-center trial. J. Infect. Dis. 189 1341-1347.
5. J.K. Benedetti, L. Corey and R. Ashley (1994) Recurrence rates in genital herpes after symptomatic first-episode infection. Ann. Intern. Med. 121 847-854.
6. R. Engleberg, D. Carrell, E. Krantz, et al. (2003) Natural history of genital herpes simplex virus type 1 infection. Sex. Transm. Dis. 30 174-177.
7. Y. Bryson, M. Dillon, D.I. Bernstein, et al. (1993) Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes: a prospective couple study. J. Infect. Dis. 167 942-946.
8. A. Wald, S. Selke, T. Warren, et al. (2006) Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding. Sex. Transm. Dis. 33 529-533.
9. K. Holcomb and J.M. Weinbery (2006) A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia. J. Drugs Dermatol. 5 863-866.
10. L.E. French (2006) Toxic epidermal necrolysis and Stevens–Johnson syndrome: our current understanding. Allergol. Int. 55 9-16.
11. B. Khalili and S.L. Bahna (2006) Pathogenesis and recent therapeutic trends in Stevens–Johnson syndrome and toxic epidermal necrolysis. Ann. Allergy Asthma Immunol. 97 272-280.
12. J. Trent, M. Halem, L.E. French, et al. (2006) Toxic epidermal necrolysis and intravenous immunoglobulin: a review. Semin. Cutan. Med. Surg. 25 91-93.
13. L.E. French, J.T. Trent and F.A. Kerdel (2006) Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens–Johnson syndrome: our current understanding. Int. Immunopharmacol. 6 543-549.
14. N. Bachot, J. Revuz and J.C. Roujeau (2003) Intravenous immunoglobulin treatment for Stevens–Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression. Arch. Dermatol. 139 33-36.
15. J.M. Arevalo, J.A. Lorente, C. Gonzalez-Herrada, et al. (2000) Treatment of toxic epidermal necrolysis with cyclosporine A. J. Trauma. 48 473-478.
16. E. Meneux, B.J. Paniel, F. Pouget, et al. (1997) Vulvovaginal sequelae in toxic epidermal necrolysis. J. Reprod. Med. 42 153-156.
17. V.N. Sehgal and G. Srivastava (2006) Fixed drug eruption (FDE): changing scenario of incriminating drugs. Int. J. Dermatol. 45 897-908.
18. S.R. Hoque and M. Patel (2006) Childhood cicatricial pemphigoid confined to the vulva. Clin. Exp. Dermatol. 31 63-64.
19. A. Schoeffler, B. Roth, A. Causeret, et al. (2004) Vulvara cicatricial pemphigoid of childhood. Pediatr. Dermatol. 21 51-53.
20. J.H. Chang and P.J. McCluskey (2005) Ocular cicatricial pemphigoid: manifestations and management. Curr. Allergy Asthma Rep. 5 333-338.
21. M.J. Canizares, D.I. Smith, M.S. Conners, et al. (2006) Successful treatment of mucous membrane pemphigoid with etanercept in 3 patients. Arch. Dermatol. 142 1457-1461.
22. M.P. Hoffernan and D.D. Bentley (2006) Successful treatment of mucous membrane pemphigoid with infliximab. Arch. Dermatol. 142 1268-1270.
23. C. Gunther, G. Wozel, M. Meurer, et al. (2004) Topical tacrolimus treatment for cicatricial pemphigoid. J. Am. Acad. Dermatol. 50 325-326.
24. A.R. Ahmed (2004) Treatment of autoimmune mucocutaneous blistering diseases with intravenous immunoglobulin therapy. Exp. Opin. Invest. Drugs. 13 1019-1032.
25. J.G. Beauman (2005) Genital herpes: a review. Am. Fam. Physician. 72 1527-1534.
26. P. Leone (2005) Reducing the risk of transmitting genital herpes: advances in understanding and therapy. Curr, Med. Res. Opin. 21 1577-1582.
27. U. Heininger and J.F. Seward (2006) Varicella. Lancet 368 1365-1376.
28. R.H. Dworkin, R.W. Johnson, J. Breuer, et al. (2007) Recommendations for the management of herpes zoster. Clin. Infect. Dis. 44(Suppl 1), S1-S26.
29. D. Niv and A. Maltsman-Tseikhin (2005) Postherpetic neuralgia: the never-ending challenge. Pain Pract 3 327-340.
30. B. Sederholm and D. Peterson (2006) Zoster vaccine to prevent postherpetic neuralgia. J. Pain Palliat. Care Pharmacother. 20 41-42.
31. K.K. Roy, R. Agarwal, S. Agarwal, et al. (2006) Recurrent vulval congenital lymphangioma circumscriptum – a case report and literature review. Int. J. Gynecol Cancer. 16 930–034
32. L.E. French (2006) Toxic epidermal necrolysis and Stevens–Johnson syndrome: our current understanding. Allergol. Int. 55 9-16.
33. B. Khalili and S.L. Bahna (2006) Pathogenesis and recent therapeutic trends in Stevens–Johnson syndrome and toxic epidermal necrolysis. Ann. Allergy Asthma Immunol. 97 272-280.
34. F.A. Pereira, A.V. Mudgil and D.M. Rosmarin (2007) Toxic epidermal necrolysis. J. Am. Acad. Dermatol. 56 181-200.
35. V.N. Sehgal and G. Srivastava (2006) Fixed drug eruption (FDE): changing scenario of incriminating drugs. Int. J. Dermatol. 45 897-908.
36. L. Edwards (2004) Vulvar fissures: causes and therapy. Dermatol. Ther. 17 111-116.
37. A.T. Goldstein, G.J. Anhalt, D. Kligman, et al. (2005) Mucous membrane pemphigoid of the vulva. Obstet. Gynecol. 105 1188-1190.
38. C. Sacher and N. Hunzelmann (2005) Cicatricial pemphigoid (mucous membrane pemphigoid): current and emerging therapeutic approaches. Am. J. Clin. Dermatol. 6 93-103.